Wei Bu

发表

Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV

H. Balfour, J. Cohen, Hui Liu, 2016, Clinical and Vaccine Immunology.

Kaposi's Sarcoma-Associated Herpesvirus Lytic Switch Protein Stimulates DNA Binding of RBP-Jk/CSL To Activate the Notch Pathway

Sanjay Tyagi, S. Marras, S. J. Lynch, 2006, Journal of Virology.

A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice

S. Pittaluga, G. Nabel, J. Cohen, 2022, Science Translational Medicine.

Maternal Epstein-Barr virus-specific antibodies and risk of infection in Ugandan infants.

Abigail Wall, A. McGuire, J. Cohen, 2020, The Journal of infectious diseases.

A bivalent EBV vaccine induces neutralizing antibodies that block B and epithelial cell infection and confer immunity in humanized mice

S. Pittaluga, G. Nabel, Chih-Jen Wei, 2022, bioRxiv.

Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

Ryan C. Burdick, V. Pathak, Jessica L Smith, 2009, Trends in pharmacological sciences.

MULTIPLE WAYS OF TARGETING APOBEC3/VIF INTERACTIONS FOR ANTI-HIV-1 DRUG DEVELOPMENT

Ryan C. Burdick, Jessica L Smith, Wei Bu, 2009 .

Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk

Chien-Jen Chen, A. Hildesheim, J. Cohen, 2018, The Journal of infectious diseases.

Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition.

J. Mascola, S. Pittaluga, M. Kanekiyo, 2022, Immunity.

Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells.

M. Rossmann, G. Nabel, M. Kanekiyo, 2019, Immunity.

Salvianolic acid-modified chitosan particle for shift intestinal microbiota composition and metabolism to reduce benzopyrene toxicity for mice

Bo Yuan, Wei Bu, G. Dong, 2022, Journal of Drug Delivery Science and Technology.

Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 ORF50/Rta Lytic Switch Protein Functions as a Tetramer

D. Lukac, Wei Bu, K. Carroll, 2007, Journal of Virology.

HLA-DQ β1 alleles associated with Epstein-Barr virus (EBV) infectivity and EBV gp42 binding to cells.

C. Hess, Qingxue Li, J. Cohen, 2017, JCI insight.

Identification of Direct Transcriptional Targets of the Kaposi's Sarcoma-Associated Herpesvirus Rta Lytic Switch Protein by Conditional Nuclear Localization

D. Lukac, V. Aris, P. Soteropoulos, 2008, Journal of Virology.

Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in Caucasians.

F. Collins, T. Myers, E. Jaffe, 2019, Blood.

Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

U. Baxa, J. Mascola, M. Rossmann, 2015, Cell.

Structural insights into hepatitis C virus receptor binding and entry

J. Cohen, J. Marcotrigiano, A. Grakoui, 2021, Nature.

APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms

V. Pathak, J. Mbisa, Wei Bu, 2010, Journal of Virology.

High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma

Chien-Jen Chen, A. Hildesheim, P. Lou, 2016, Clinical Cancer Research.

Proceedings of the 7th Biannual International Symposium on Nasopharyngeal Carcinoma 2015

Sugiyanto, Asma Abdul Rahman, C. Lemmen, 2016, BMC Proceedings.

The 150 most important questions in cancer research and clinical oncology series: Questions 31-39

J. Cohen, Jilong Yang, Li Zhang, 2017 .

DDDT_A_233023 2355..2370

Wei Zhang, Jinyi Cao, Yang Yang, 2020 .